Claims
- 1. A method comprising the steps of:
(a) providing a sample suspension containing at least one set of G protein beads, each of said G-protein beads comprising epitope-recognizing beads having a heterotrimeric G protein bound thereto; (b) mixing said sample suspension with at least one type of G protein coupled receptor and a ligand to thereby form a mixed suspension containing a ligand-receptor-G protein complex when said G protein is capable of forming complex with said receptor and said ligand; (c) mixing said mixed suspension to incubate said mixed suspension and thereby form an incubated suspension; (d) detecting the formation of a stable ligand-receptor-G protein complexes in said incubated suspension by flow cytometry.
- 2. The method of claim 1, further comprising the step of determining whether said G protein is capable of forming a complex with said receptor and said ligand, wherein said receptor and said ligand are known to form a complex with an unknown G protein.
- 3. The method of claim 1, further comprising the step of determining whether said ligand is capable of forming a complex with said G protein and said receptor, wherein said G protein and said receptor are known to form a complex with another ligand.
- 4. The method of claim 1, further comprising forming said G protein beads by binding epitope-bearing G protein subunits to epitope-recognizing beads.
- 5. The method of claim 1, wherein said eptitope-recognizing beads comprise beads that recognize the FLAG epitope.
- 6. The method of claim 1, wherein said epitope-recognizing beads comprise beads that recognize the six-histidine (H6) epitope.
- 7. The method of claim 1, further comprising the step of solubilizing said receptor.
- 8. The method of claim 1, wherein said epitope-recognizing beads are derivatized to carry chelated nickel.
- 9. The method of claim 1, wherein said heterotrimeric G protein includes a fluorescent tag.
- 10. The method of claim 1, wherein said ligand includes a fluorescent tag.
- 11. The method of claim 1, wherein said receptor is fluorescent.
- 12. The method of claim 11, wherein said receptor is made fluorescent by chemical derivatization of said receptor.
- 13. The method of claim 11, wherein said receptor is made fluorescent by making a fusion protein of said receptor with a fluorescent protein.
- 14. The method of claim 1, wherein said at least one set of G protein beads comprises at least two sets of G protein beads, each of said sets of G protein beads having a different respective fluorescent color and a different respective heterotrimeric G protein bound thereto; wherein all of said sets of G protein beads are simultaneously present in said mixed suspension; and wherein step (d) comprises detecting the respective fluorescent color associated with each set of G protein beads separately.
- 15. The method of claim 14, wherein said at least one type of G protein coupled receptor comprises at least two types of G protein coupled receptors.
- 16. The method of claim 1, wherein said at least one type of G protein coupled receptor comprises at least two types of G protein coupled receptors, each of said types of G protein coupled receptors having a different fluorescent color; wherein all of said types of G protein coupled receptors are simultaneously present in said mixed suspension; and wherein step (d) comprises detecting the respective fluorescent color associated with each of said types of G protein coupled receptors separately.
- 17. The method of claim 1, wherein G protein beads have a first fluorescent color, wherein said ligand is bound to ligand bearing beads having a second fluorescent color, wherein said G protein beads and said ligand bearing beads are present simultaneously in said mixed suspension, and wherein step (d) comprises detecting the respective fluorescent color associated with said G protein beads and said ligand bearing beads separately.
- 18. The method of claim 1, wherein a regulator of G protein signaling is mixed with said mixed suspension and wherein said method further comprises the following step:
(e) determining the effect of said regulator of G protein signaling upon ternary complex formation.
- 19. The method of claim 18, wherein said at least one set of G protein beads comprises at least two sets of G protein beads, each of said sets of G protein beads having a different respective fluorescent color and a different respective heterotrimeric G protein bound thereto; wherein all of said sets of G protein beads are simultaneously present in said mixed suspension; wherein step (d) comprises detecting the respective fluorescent color associated with each set of G protein beads separately, and wherein step (e) comprises determining the effect of said regulator of G protein signaling upon ternary complex formation for each of said sets of G protein beads.
- 20. The method of claim 19, wherein said at least one type of G protein coupled receptor comprises at least two types of G protein coupled receptors and wherein step (e) comprises determining the effect of said regulator of G protein signaling upon ternary complex formation for each of said types of G protein coupled receptors.
- 21. The method of claim 18, wherein said at least one type of G protein coupled receptor comprises at least two types of G protein coupled receptors, each of said types of G protein coupled receptors having a different fluorescent color; wherein all of said types of G protein coupled receptors are simultaneously present in said mixed suspension; wherein step (d) comprises detecting the respective fluorescent color associated with each of said types of G protein coupled receptors separately; and wherein step (e) comprises determining the effect of said regulator of G protein signaling upon ternary complex formation for each of said types of G protein coupled receptors.
- 22. A method of forming G protein beads comprising the steps of:
providing epitope-recognizing beads; and binding epitope-bearing G protein subunits to said epitope-recognizing beads to form G protein beads.
- 23. The method of claim 22, wherein said eptitope-recognizing beads comprise beads that recognize the FLAG eptitope.
- 24. The method of claim 22, wherein said eptitope-recognizing beads comprise beads that recognize the six-histidine (H6) epitope.
- 25. The method of claim 22, wherein said epitope-recognizing beads are derivatized to canny chelated nickel.
- 26. The method of claim 22, wherein said heterotrimeric G protein includes a fluorescent tag.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This continuation-in-part application makes reference to and claims priority to U.S. Provisional Patent Application No. 60/378,536, entitled “Drug Discovery Systems and Methods and Compounds for Drug Delivery,” filed May 6, 2002, and U.S. patent application Ser. No. 09/370,358, entitled “Display of Receptors and Analysis of Binding Interactions and Drug Libraries,” filed Aug. 9, 1999, which claims priority to U.S. Provisional Patent Application No. 60/096,010, entitled “Solid Phase Display of Combinatorial Libraries and Non-Cellular Display of 7 TMR,” filed Aug. 10, 1998. The entire disclosures and contents of the above applications are hereby incorporated by reference.
GOVERNMENT INTEREST STATEMENT
[0002] This invention is made with government support under Grant Numbers GM60799/EB-00264, HL-46417, GM-39561 awarded by the National Institutes of Health and Grant Number MCB-9907611 awarded by the National Science Foundation. The government may have certain rights in this invention.
Provisional Applications (2)
|
Number |
Date |
Country |
|
60378536 |
May 2002 |
US |
|
60096010 |
Aug 1998 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09370358 |
Aug 1999 |
US |
Child |
10429042 |
May 2003 |
US |